drugset / Trial / NCT00666653

Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease

NCT00666653

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether there is a benefit to giving a dopamine agonist to a patient with Parkinson's disease who is already being treated with levodopa.

Timeline

Start
2003-07
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramipexole Unknown 1 mg Oral

Indications